🔥🐔 BizChicken 🐔🔥

Companies Similar to IRIDEX Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Eyenovia, Inc.

Eyenovia, Inc. logo
Market Cap: Lowest
Employees: Lowest

Optejet

Eyenovia, Inc. is focused on developing therapeutic solutions for ophthalmic conditions using its proprietary microdose array print platform and Optejet delivery system. It targets conditions like progressive myopia, presbyopia, and mydriasis.

Tags: Optejet, microdosing, mydriasis, myopia, ophthalmic, pharmaceuticals, presbyopia, therapeutics

Symbol: EYEN

Recent Price: $0.11

Industry: Biotechnology

CEO: Mr. Michael M. Rowe

Sector: Healthcare

Employees: 57

Address: 295 Madison Avenue, New York, NY 10017

Phone: 917 289 1117

Leadership

  • Charles Mather, Chairman of the Board
  • Ellen Strahlman, MD, MS, Independent Director
  • Sean Ianchulev, MD, MPH, Director
  • Michael Geltzeiler, Independent Director
  • Rachel Jacobson, Independent Director
  • Ram Palanki, PharmD, Independent Director
  • Michael Rowe, Director

Last updated: 2024-12-31

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. logo
Market Cap: Highest
Employees: Highest

EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb

Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.

Tags: biotechnology, diseases, healthcare, injections, medicines, pharmaceuticals, treatment

Symbol: REGN

Recent Price: $702.59

Industry: Biotechnology

CEO: Dr. Leonard S. Schleifer M.D., Ph.D.

Sector: Healthcare

Employees: 14165

Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Phone: 914 847 7000

Leadership

  • Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
  • George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
  • Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
  • Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
  • Leonard Brooks, Senior Vice President, Treasurer
  • John Calabro, Senior Vice President, Internal Audit
  • Christina Chan, Senior Vice President, Corporate Affairs
  • Larry Coury, PhD, Senior Vice President, Associate General Counsel
  • Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
  • Matthew Everett, Senior Vice President, Global Procurement
  • Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
  • Rick Hall, Senior Vice President, Human Resources
  • Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
  • Nouhad Husseini, Senior Vice President, Business Development
  • Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
  • Melissa Lozner, Senior Vice President, Chief Compliance Officer
  • Marion McCourt, Executive Vice President, Commercial
  • Bob McCowan, Senior Vice President, IT and Chief Information Officer
  • Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
  • Richard O’Neal, Senior Vice President, Market Access
  • Sally A. Paull, Executive Vice President, Human Resources
  • Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
  • George Poth, Senior Vice President, Real Estate & Facilities Management
  • Alessandra Ravetti, Senior Vice President, Associate General Counsel
  • Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
  • David Snow, Senior Vice President, Global Head, Dupixent Franchise
  • Mark Volpe, Senior Vice President, Tax
  • Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
  • Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
  • Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
  • Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
  • Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
  • Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
  • Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
  • Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
  • Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
  • Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
  • Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
  • Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
  • Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
  • Christos Kyratsous, PhD, Senior Vice President, Research
  • Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
  • John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
  • Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
  • Lynn Macdonald, PhD, Senior Vice President, Research
  • Lori Morton, PhD, Senior Vice President, Research
  • Andrew Murphy, PhD, Executive Vice President, Research
  • Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
  • William Olson, PhD, Senior Vice President, Therapeutic Proteins
  • Mohammed Shameem, PhD, Senior Vice President, Formulations Development
  • L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
  • Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
  • Neil Stahl, PhD, Executive Vice President, Research and Development
  • Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
  • Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
  • Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
  • Frederick Austin, Senior Vice President, Quality Control, Raheen
  • Christine Childrose, Senior Vice President, Human Resources and HR Operations
  • David Crenshaw, Senior Vice President, Associate General Counsel
  • Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
  • Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
  • Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
  • Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
  • Scott Oberman, Senior Vice President, Supply Chain Operations
  • David Simon, Senior Vice President, IOPS Finance and Business Operations
  • Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
  • Benjamin Yocum, Senior Vice President, Manufacturing Operations
  • James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
  • Bonnie L. Bassler, PhD, Director
  • Michael S. Brown, MD, Director
  • N. Anthony Coles, MD, Chair of the Board
  • Joseph L. Goldstein, MD, Director
  • Kathryn Guarini, PhD, Director
  • Christine A. Poon, Lead Independent Director
  • Arthur F. Ryan, Director
  • Huda Y. Zoghbi, MD, Director
  • Samantha Dickon, Director, Development Program Management
  • Gervasio Batista, Sr. Scientist, Neuroscience
  • James K. Gibson, Senior Regional Director, Immunology/Pulmonary
  • Beth Brause, Director, Field Reimbursement Management
  • Eric Prendergast, Director, Pricing Strategy
  • Ashley Neff, Manager, Digital Communications
  • Shari Loock, Associate Director, Sourcing
  • Jennifer Davidson Hamilton, VP and Head of Precision Medicine
  • Yi Zhang, Director, Health Economics & Outcomes Research
  • Wilson Caldwell III, Director, GCO Vendor & Relationship Management
  • David Stein, Director, Medical Operations
  • Regeneron, Corporate
  • Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
  • Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
  • Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
  • Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
  • Jessie Brown, Manager, Integrative Translational Genetics
  • Gisu Eom, Lead Cloud DevOps Engineer
  • Carmen Kenworthy, Scientist, Velocigene
  • Ralph Hazlewood, Sr. Manager, Research Program Management
  • Brandy Bennett, Sr. Director, R&D Strategy & Operations

Last updated: 2024-12-31

Precision Optics Corporation, Inc.

Precision Optics Corporation, Inc. logo
Market Cap: Lowest
Employees: Low

Microprecision lenses, micro medical cameras, 3D endoscopes

Precision Optics Corporation, Inc. designs, manufactures, and sells specialized optical systems and components, particularly for medical, industrial, and military use, including advanced medical imaging products like endoscopes.

Tags: custom imaging, endoscopes, illumination systems, industrial, medical instrumentation, military, minimally invasive surgery, optics

Symbol: POCI

Recent Price: $4.93

Industry: Medical - Instruments & Supplies

CEO: Dr. Joseph N. Forkey

Sector: Healthcare

Employees: 83

Address: 22 East Broadway, Gardner, MA 01440

Phone: 978 630 1800

Last updated: 2024-12-31

Glaukos Corporation

Glaukos Corporation logo
Market Cap: Highest
Employees: Medium

i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR

Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.

Tags: corneal disorders, glaucoma treatment, i Dose TR, i Stent, medical technology, ophthalmic, pharmaceutical, retinal diseases

Symbol: GKOS

Recent Price: $149.51

Industry: Medical - Devices

CEO: Mr. Thomas William Burns

Sector: Healthcare

Employees: 907

Address: 229 Avenida Fabricante, San Clemente, CA 92672

Phone: 949 367 9600

Last updated: 2024-12-31

Clearside Biomedical, Inc.

Clearside Biomedical, Inc. logo
Market Cap: Low
Employees: Lowest

XIPERE

Clearside Biomedical, Inc. is a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. They offer treatments such as XIPERE for uveitis macular edema and are developing additional therapies for ocular conditions.

Tags: XIPERE, biopharmaceutical, clinical trials, macular edema, ocular therapies, suprachoroidal injection, uveitis

Symbol: CLSD

Recent Price: $0.99

Industry: Biotechnology

CEO: Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.

Sector: Healthcare

Employees: 30

Address: 900 North Point Parkway, Alpharetta, GA 30005

Phone: 678 270 3631

Last updated: 2024-12-31

Cytek Biosciences, Inc.

Cytek Biosciences, Inc. logo
Market Cap: Medium
Employees: Medium

Aurora and Northern Lights Systems

Cytek Biosciences, Inc. provides cell analysis solutions with tools such as spectrum flow cytometers and reagents that advance biomedical research and clinical applications.

Tags: biomedical research, cell analysis, clinical applications, fluorescence, immunoprofiling, spectrum flow cytometers

Symbol: CTKB

Recent Price: $6.55

Industry: Medical - Devices

CEO: Dr. Wenbin Jiang Ph.D.

Sector: Healthcare

Employees: 676

Address: 47215 Lakeview Boulevard, Fremont, CA 94538

Phone: 877 922 9835

Last updated: 2024-12-31

Journey Medical Corporation

Journey Medical Corporation logo
Market Cap: Low
Employees: Lowest

Qbrexza, Accutane, Targadox, Ximino, Exelderm

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for treating dermatological conditions in the United States. It offers various products for hyperhidrosis and acne treatment and more.

Tags: Acne Treatment, Dermatology, Healthcare, Hyperhidrosis, Pharmaceutical

Symbol: DERM

Recent Price: $3.97

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Claude Maraoui

Sector: Healthcare

Employees: 41

Address: 9237 East Via de Ventura Boulevard, Scottsdale, AZ 85258

Phone: 480 434 6670

Last updated: 2024-12-31

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50

Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.

Tags: DEXYCU, ILUVIEN, YUTIQ, biotechnology, eye diseases, eye health, micro-insert, ophthalmic, ophthalmology, pharmaceutical, treatment, vision

Symbol: EYPT

Recent Price: $7.02

Industry: Biotechnology

CEO: Dr. Jay S. Duker M.D.

Sector: Healthcare

Employees: 121

Address: 480 Pleasant Street, Watertown, MA 02472

Phone: 617 926 5000

Last updated: 2024-12-31

Harrow Health, Inc.

Harrow Health, Inc. logo
Market Cap: High
Employees: Low

Imprimis Rx, DEXYCU

Harrow Health, Inc. is an ophthalmic-focused healthcare company owning several pharmaceutical businesses and equity interests in clinical-stage companies, dedicated to innovative treatments in eye health and anesthesia.

Tags: drug development, healthcare, ophthalmic-focused, ophthalmology, pharmaceuticals, therapeutics

Symbol: HROW

Recent Price: $33.38

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark L. Baum J.D.

Sector: Healthcare

Employees: 315

Address: 102 Woodmont Boulevard, Nashville, TN 37205

Phone: 615 733 4730

Last updated: 2024-12-31

IRIDEX Corporation

IRIDEX Corporation logo
Market Cap: Lowest
Employees: Low

Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems

IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.

Tags: diabetic macular edema, eye diseases, glaucoma treatment, medical lasers, ophthalmic technology, retinal diseases

Symbol: IRIX

Recent Price: $1.74

Industry: Medical - Devices

CEO: Mr. Patrick Mercer

Sector: Healthcare

Employees: 111

Address: 1212 Terra Bella Avenue, Mountain View, CA 94043

Phone: 650 940 4700

Last updated: 2024-12-31

IRadimed Corporation

IRadimed Corporation logo
Market Cap: Medium
Employees: Low

MRidium MRI compatible infusion pump system and MRI compatible patient vital signs monitoring system

IRADIMED CORPORATION develops, manufactures, and distributes MRI-compatible medical devices and accessories, serving hospitals and imaging centers worldwide.

Tags: MRI compatible devices, healthcare, infusion pump, medical devices, patient monitoring

Symbol: IRMD

Recent Price: $55.09

Industry: Medical - Devices

CEO: Mr. Roger E. Susi

Sector: Healthcare

Employees: 148

Address: 1025 Willa Springs Drive, Winter Springs, FL 32708

Phone: 407 677 8022

Last updated: 2024-12-31

Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

KIO-301

Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.

Tags: clinical trials, ophthalmic diseases, ophthalmology, pharmaceuticals, vision restoration

Symbol: KPRX

Recent Price: $3.30

Industry: Biotechnology

CEO: Dr. Brian M. Strem Ph.D.

Sector: Healthcare

Employees: 12

Address: 1371 East 2100 South, Salt Lake City, UT 84105

Phone: 781 788 8869

Last updated: 2024-12-31

Ocugen, Inc.

Ocugen, Inc. logo
Market Cap: Low
Employees: Low

OCU400, OCU410, OCU200

Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases. Its product pipeline includes gene therapy candidates targeting various retinal diseases and other conditions.

Tags: biopharmaceutical, blindness diseases, gene therapy, retinal diseases, strategic partnership

Symbol: OCGN

Recent Price: $0.81

Industry: Biotechnology

CEO: Dr. Shankar Musunuri M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 263 Great Valley Parkway, Malvern, PA 19355

Phone: 484 328 4701

Last updated: 2024-12-31

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. logo
Market Cap: High
Employees: Low

Re Sure Sealant; DEXTENZA; OTX-TKI; OTX-TIC; OTX-CSI

Ocular Therapeutix is a biopharmaceutical company that develops and commercializes therapies for eye diseases using bioresorbable hydrogel-based technology, offering products like Re Sure Sealant and DEXTENZA.

Tags: biopharmaceutical, eye care, hydrogel, ophthalmic devices, ophthalmology, therapy

Symbol: OCUL

Recent Price: $8.35

Industry: Biotechnology

CEO: Dr. Pravin U. Dugel M.D.

Sector: Healthcare

Employees: 267

Address: 24 Crosby Drive, Bedford, MA 01730

Phone: 781 357 4000

Leadership

  • Pravin U. Dugel, MD, Executive Chairman, President and CEO
  • Karen-Leigh Edwards, PhD, MBA, Chief Operations Officer
  • Peter Jarrett, PhD, Chief Technical Officer
  • Donald Notman, Chief Financial Officer and Chief Operating Officer
  • Nadia K. Waheed, MD, MPH, Chief Medical Officer
  • Jeffrey S. Heier, MD, Chief Scientific Officer
  • Steve Meyers, Chief Commercial Officer
  • Tracy Smith, Vice President, Human Resources
  • Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
  • Peter K. Kaiser, MD, Chief Development Officer
  • Todd Anderman, JD, Chief Legal Officer and Corporate Secretary
  • Charles Warden, Lead Independent Director
  • Adrienne Graves, PhD, Director
  • Leslie Williams, Director
  • Richard Lindstrom, MD, Director
  • Seung Suh Hong, PhD, Director
  • Merilee Raines, Director

Last updated: 2024-12-31

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Nyxol

Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

Tags: biopharmaceutical, clinical trials, ophthalmic, refractive disorders, retinal disorders

Symbol: OCUP

Recent Price: $1.17

Industry: Biotechnology

CEO: Mr. George Magrath M.B.A., M.D., M.S.

Sector: Healthcare

Employees: 14

Address: 37000 Grand River Avenue, Farmington Hills, MI 48335

Phone: 248 681 9815

Last updated: 2024-12-31

RxSight, Inc.

RxSight, Inc. logo
Market Cap: High
Employees: Medium

Rx Sight system

Rx Sight, Inc. is a medical technology company specializing in light adjustable intraocular lenses used in cataract surgery, allowing for post-operative customization of visual acuity.

Tags: Rx Sight system, cataract surgery, intraocular lenses, medical technology, visual acuity

Symbol: RXST

Recent Price: $33.81

Industry: Medical - Devices

CEO: Dr. Ronald M. Kurtz M.D.

Sector: Healthcare

Employees: 374

Address: 100 Columbia, Aliso Viejo, CA 92656

Phone: 949 521 7830

Last updated: 2024-12-31

Sight Sciences, Inc.

Sight Sciences, Inc. logo
Market Cap: Low
Employees: Low

OMNI Surgical System, Tear Care System

Sight Sciences, Inc., is a company focused on developing and commercializing surgical and nonsurgical technologies for treating eye diseases, including products like the OMNI Surgical System for glaucoma and Tear Care System for dry eye disease.

Tags: dry eye disease, eye diseases, glaucoma, healthcare, medical device, ophthalmic, technology

Symbol: SGHT

Recent Price: $3.53

Industry: Medical - Devices

CEO: Mr. Paul Badawi

Sector: Healthcare

Employees: 214

Address: 4040 Campbell Avenue, Menlo Park, CA 94025

Phone: 877 266 1144

Last updated: 2024-12-31

Acelyrin, Inc.

Acelyrin, Inc. logo
Market Cap: Medium
Employees: Low

izokibep

Acelyrin, Inc. is a clinical biopharma company focused on developing and commercializing transformative medicines, with key products targeting conditions like Hidradenitis Suppurativa and Psoriatic Arthritis.

Tags: Biopharma, Clinical Trials, Hidradenitis Suppurativa, Psoriatic Arthritis, Transformative Medicines

Symbol: SLRN

Recent Price: $3.08

Industry: Biotechnology

CEO: Ms. Mina Kim

Sector: Healthcare

Employees: 93

Address: 4149 Liberty Canyon Road, Agoura Hills, CA 91301

Phone: 805-730-0360

Last updated: 2024-12-31

Coherent, Inc.

Coherent, Inc. logo
Market Cap: Highest
Employees: Highest

lasers and laser-based technologies

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for commercial, industrial, and scientific research applications, operating in segments of OEM Laser Sources and Industrial Lasers & Systems.

Tags: industrial, laser-based technologies, lasers, precision optics, scientific research

Symbol: COHR

Recent Price: $94.84

Industry: Hardware, Equipment & Parts

CEO: Mr. James Robert Anderson

Sector: Technology

Employees: 26157

Address: 5100 Patrick Henry Drive, Santa Clara, CA 95054

Phone: 408 764 4000

Leadership

  • Jim Anderson, Chief Executive Officer
  • Sherri Luther, Chief Financial Officer
  • Giovanni Barbarossa, Chief Strategy Officer and President, Materials Segment
  • Sunny Sun, President, Networking Segment
  • Christopher Dorman, Executive Vice President, Lasers Segment
  • Julie Sheridan Eng, Chief Technology Officer
  • Sanjai Parthasarathi, Chief Marketing Officer
  • Rob Beard, Chief Legal and Global Affairs Officer
  • Magnus Bengtsson, Chief Commercial Officer
  • Timothy A. Challingsworth, Chief Sustainability Officer
  • Young-Kai (Y.K.) Chen, Deputy Chief Technology Officer
  • Abhay Edlabadkar, Chief Transformation Officer
  • Anantha Ganga, Chief Information Officer
  • Gary A. Kapusta, Executive VP, Operations
  • Sohail Khan, Executive Vice President, Silicon Carbide LLC
  • Chris Koeppen, Chief Innovation Officer
  • Marie Batz Martin, Chief Compliance Officer
  • Richard J. Martucci, SVP Business Operations
  • Beck Mason, Executive VP, Telecommunications
  • Ilaria Mocciaro, Senior Vice President, Chief Accounting Officer, and Controller
  • Craig Mullaney, Chief of Staff and Strategic Advisor
  • Paul Silverstein, Senior Vice President, Investor Relations & Corporate Communications
  • Chris Theis, Chief Quality Officer
  • Lee Xu, Executive VP, Datacom Transceivers
  • Chiew Mee Yong, Chief Human Resources Officer

Last updated: 2024-12-31

LENSAR, Inc.

LENSAR, Inc. logo
Market Cap: Lowest
Employees: Low

LENSAR Laser System

LENSAR, Inc. is a commercial-stage medical device company specializing in the design, development, and marketing of a femtosecond laser system for cataract treatment and corneal astigmatism management.

Tags: cataract treatment, corneal astigmatism, healthcare technology, laser system, medical device

Symbol: LNSR

Recent Price: $8.66

Industry: Medical - Devices

CEO: Mr. Nicholas T. Curtis

Sector: Healthcare

Employees: 130

Address: 2800 Discovery Drive, Orlando, FL 32826

Phone: 888 536 7271

Last updated: 2024-12-31